WaveMan
WaveMan · Form 4
Sanders Corazon (Corsee) D. insider trades
> Search tickers & screens ⌘K
LIVE

Sanders Corazon (Corsee) D. insider trades

Sanders Corazon (Corsee) D. has filed 24 Form 4s with the SEC that we hold, for Ultragenyx Pharmaceutical Inc. (RARE) (Director), BeOne Medicines Ltd. (ONC) (Director), MTEM (Director) and Legend Biotech Corp (LEGN) (Director), among 5 companies in all. Across all of them we count 0 purchases worth $0 and 13 sales worth $2.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($1.3M). The largest single trade was a sale of 2,665 shares of BeOne Medicines Ltd. worth $898.1K, dated 2025-09-05. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-06-06 and the latest 2026-10-01.

Ultragenyx Pharmaceutical Inc. (RARE)

Director · 10 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiledSource
2023-06-08S, sale reported on Form 41,485$76.7K2023-06-09SEC
2023-06-30S, sale reported on Form 4585$27.4K2023-06-30SEC
2024-06-10S, sale reported on Form 41,737$71.4K2024-06-10SEC
2024-07-02S, sale reported on Form 4584$23.9K2024-07-03SEC
2025-06-20S, sale reported on Form 42,405$89.9K2025-06-23SEC
2026-06-15S, sale reported on Form 42,000$50.1K2026-06-15SEC

BeOne Medicines Ltd. (ONC)

Director · 8 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiledSource
2023-06-23S, sale reported on Form 4478$87.3K2023-06-27SEC
2023-06-23S, sale reported on Form 4100$18.1K2023-06-27SEC
2025-09-05S, sale reported on Form 42,665$898.1K2025-09-09SEC
2025-11-26S, sale reported on Form 4804$275.3K2025-12-01SEC
2025-11-26S, sale reported on Form 41,823$620.2K2025-12-01SEC
2026-05-22S, sale reported on Form 4212$65.6K2026-05-27SEC

MTEM

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Legend Biotech Corp (LEGN)

Director · 2 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiledSource
2026-09-29S, sale reported on Form 427,370$258.9K2026-10-01SEC

Calidi Biotherapeutics, Inc. (CLDI)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1796536) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms